ALNY
Alnylam Pharmaceuticals, Inc.
Stock
$219.72−11.46 (−4.96%)Close Oct 2, 2026
- Cash and short-term investments, 2025
- $2.9B
- YoY, 2025
- +8.3%
- 5-year CAGR
- +9.7%
- 10-year CAGR
- +10.9%
Cash and short-term investments
Cash and short-term investments by fiscal year
| Period | Cash | YoY |
|---|---|---|
| 2025 | $2.9B | +8.3% |
| 2024 | $2.7B | +10.6% |
| 2023 | $2.4B | +12.2% |
| 2022 | $2.2B | −8.6% |
| 2021 | $2.4B | +29.4% |
| 2020 | $1.8B | +20.2% |
| 2019 | $1.5B | +40.6% |
| 2018 | $1.1B | −35.9% |
| 2017 | $1.7B | +173.7% |
| 2016 | $618M | −40.0% |
| 2015 | $1.0B | +70.9% |
| 2014 | $602M | +144.9% |
| 2013 | $246M | +100.2% |
| 2012 | $123M | −16.1% |
| 2011 | $146M | −37.2% |
| 2010 | $233M | −17.2% |
| 2009 | $281M | +46.7% |
| 2008 | $192M | — |